Remove 2005 Remove Medicine Remove Pharmaceutical products Remove Safety
article thumbnail

Quality by design with a focus on biosimilars

Pharmaceutical Technology

Quality by design (QbD) is a concept introduced into the pharmaceutical regulatory lexicon in 2005. It aims to ensure the quality of medicines by employing statistical, analytical, and risk-management methodology in the design, development, and manufacturing processes of medicines.

article thumbnail

The imperative of fridge-free vaccines

European Pharmaceutical Review

One example of such a technology is that recently used to convert a commercial tetanus-diphtheria vaccine usually requiring refrigeration at 2-8°C into a room temperature product that is stable and fully‑protective in Guinea pigs after storage at 45°C for 7-12 months. Injection Safety Fact Sheet. Woodhead Publishing. Pages 20-27.